• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OPSENS OPTOWIRE III; CORONARY PRESSURE GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OPSENS OPTOWIRE III; CORONARY PRESSURE GUIDEWIRE Back to Search Results
Model Number F1031
Device Problem Mechanical Problem (1384)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/24/2023
Event Type  malfunction  
Event Description
Opsens was informed by the distributor that optowire was advanced into a significantly calcified lesion in the lad, it was noticed that the wire was broken where proximal radiopaque section stops.Wire tip was safely removed, and patient is doing well.Opsens was informed by the distributor that optowire was advanced into a significantly calcified lesion in the lad, it was noticed that the wire was broken where proximal radiopaque section stops.Wire tip was safely removed, and patient is doing well.
 
Manufacturer Narrative
The optowire iii could not be analysed since it was discarded by the hospital after the procedure.Review of device history records confirmed that the optowire iii lot number ow-2617e had been released as per specifications, dr610 was recorded, but not related to the complaint.Based on the available event description and following discussion with the distributor representative, the wire was fractured at the end of the distal radiopaque section.The cause of the fracture is likely related to the usage of the device beyond the recommendations provided in the instructions for use (ifu): -if resistance occurs and the cause of resistance cannot be determined, do not move or torque the optowire.Stop the procedure, determine the cause of resistance under fluoroscopy and take appropriate action.-observe optowire movement in the vessels.Before an optowire is moved or torqued, the tip movement should be examined under fluoroscopy.Do not torque an optowire without observing corresponding movement of the tip; otherwise, vessel trauma may occur.-never advance an optowire against resistance without first determining the reason for the resistance under fluoroscopy.Excessive force against resistance may result in damage to the wire and/or to the vessel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTOWIRE III
Type of Device
CORONARY PRESSURE GUIDEWIRE
Manufacturer (Section D)
OPSENS
750
blvd du parc technologique
quebec, quebec G1P 4 S3
CA  G1P 4S3
Manufacturer (Section G)
OPSENS
750
blvd du parc technologique
quebec, quebec G1P 4 S3
CA   G1P 4S3
Manufacturer Contact
maryem oudhini
750
blvd du parc technologique
quebec, quebec G1P 4-S3
CA   G1P 4S3
MDR Report Key18060648
MDR Text Key327219021
Report Number3008061490-2023-00011
Device Sequence Number1
Product Code DXO
UDI-Device Identifier07540184010325
UDI-Public(01)07540184010325(11)230421(17)260421(10)OW-2617E
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
K191907
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 10/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberF1031
Device Lot NumberOW-2617E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/11/2023
Initial Date FDA Received11/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/21/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-